FIELD: chemistry.
SUBSTANCE: described are new derivatives of imidazo-pyridine with general formula I in racemic, enantiomeric form or in combination of these forms, and their pharmaceutically used salts. Radicals R1-R4 are described in the description.
EFFECT: these compounds have affinity to melanocortin receptor; possibility of using them in making medicinal agents for treating disorders, related to body weight, mental disorders, pain, sexual activity disorders.
21 cl, 5 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW DERIVATIVES BENZIMIDAZOLE AND IMIDAZOPYRIDINE AND THEIR APPLICATION AS MEDICINES | 2004 |
|
RU2330023C2 |
NEW BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MEDICINAL AGENTS | 2004 |
|
RU2369601C2 |
NOVEL DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS MEDICAMENTS | 2002 |
|
RU2294326C2 |
4-AMINOPIPERIDINE DERIVATIVES, METHODS FOR THEIR PREPARING, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2266282C2 |
PYRIMIDOBENZIMIDAZOLE DERIVATIVES AND APPLICATION THEREOF AS AGONISTS OR ANTAGONISTS OF MELANOCORTIN RECEPTORS | 2005 |
|
RU2392279C2 |
5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVE AND THEIR USE AS MEDICINAL AGENTS | 2002 |
|
RU2367655C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINEDIONES, METHOD FOR THEIR PREPARING (VARIANTS), INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2277093C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
Authors
Dates
2009-06-20—Published
2004-03-29—Filed